Answers are grounded in this paper and cite their sources.
Background: Traumatic brain injury (TBI) remains a leading cause of death and disability worldwide, and chronic alcohol consumption is a well-recognized, modifiable contributor to its occurrence and severity. This study aimed to characterize the clinical and biochemical differences, as well as mortality outcomes, between chronic alcohol consumers and non-consumers undergoing neurosurgery for closed TBI. Methods: We retrospectively analyzed 225 adult patients surgically treated for closed TBI between 2018 and 2022 in a single neurosurgical department, classified as patients with (n = 119) or without (n = 106) documented chronic alcohol use. Continuous variables were compared with Welch’s t-test and categorical variables with Pearson’s chi-square test or Fisher’s exact test. Effect sizes for between-group comparisons and odds ratios (ORs) from the univariable and multivariable models were reported with 95% confidence intervals (CIs). A subsequent Bonferroni correction was applied. In-hospital mortality was explored using univariable and full multivariable logistic regression. An additional L1-penalized logistic regression (LASSO) model used 10-fold cross-validation within the training subset to select the penalty parameter. Performance was assessed in a held-out test subset using a confusion matrix. Results: Alcohol users were younger, predominantly male, and had higher transaminases and mean corpuscular volume (MCV), lower hemoglobin, hematocrit, and platelet counts, lower admission Glasgow Coma Scale (GCS) scores, and more frequent initial seizures. Mortality was higher (19.3% vs. 8.5%). After multivariable adjustment, the association with chronic alcohol use was attenuated. Admission GCS was the only statistically significant predictor in the full model (OR 0.70 per point, 95% CI 0.60–0.81, p < 0.001). LASSO retained hematocrit, AST, INR, and admission GCS. The LASSO mortality model showed 83.0% accuracy, 82.3% specificity, and 87.5% sensitivity on a held-out test set. Conclusions: Patients with documented chronic alcohol consumption in this cohort showed selected clinical and biochemical differences and higher crude in-hospital mortality. The mortality analysis remains exploratory and further validation is needed before individual clinical risk prediction.
No takes yet. Share an insight, caveat, or question.
Copelea et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: